Clinical and Molecular Clues to Diagnosing Hereditary Hyperferritinemia-Cataract Syndrome: Case Report and Literature Review
Genes · 2025
DOI: 10.3390/genes16111381 ↗Kurz gefasst
Fallbericht in der Zeitschrift Genes, 2025. Verfasst von Barbora Ludikova und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic. Hauptthemen laut MEDLINE: Cataract, Apoferritins, Hyperferritinemia, Iron Metabolism Disorders. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Faculty Hospital Olomouc, Palacký University Olomouc, Internal grant of Palacký University.
Abstract (Originalsprache)
Background
Hereditary hyperferritinemia-cataract syndrome (HHCS) is a rare autosomal dominant disorder characterized by persistently elevated serum ferritin and early-onset bilateral cataracts in the absence of systemic iron overload. It is caused by pathogenic variants in the iron-responsive element (IRE) of the FTL gene, leading to dysregulated L-ferritin synthesis.
Methods
We evaluated a 12-year-old Czech girl with markedly elevated serum ferritin identified incidentally during workup for abdominal pain. Clinical assessment included biochemical, radiological, ophthalmological, and genetic testing of the proband and available family members.
Results
Magnetic resonance imaging excluded systemic iron overload, while ophthalmological evaluation revealed bilateral cataracts. Family history indicated multiple affected relatives across three generations. Genetic testing confirmed a heterozygous FTL c.-168G>C variant. Additional screening for common HFE variants revealed heterozygous H63D in several family members, with no impact on ferritin or hepcidin levels. Beyond this case, we provide a comprehensive review of HHCS, including molecular mechanisms, an updated overview of reported FTL mutations, and ophthalmological features that distinguish HHCS cataracts from other congenital cataracts.
Conclusions
This report underscores the translational relevance of combining molecular diagnostics, clinical evaluation, and family screening to improve recognition and management of HHCS, and to prevent misdiagnosis and unnecessary iron-depletion therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, 779 00 Olomouc, Czech Republic.
- Department of Biology, Faculty of Medicine and Dentistry, Palacky University, 779 00 Olomouc, Czech Republic.
- Department of Pediatrics, T. Bata Regional Hospital, 762 75 Zlin, Czech Republic.
ORCID-Profile: Lucie Sochorcova, Katarina Hlusickova Kapralova, Monika Horvathova
Förderung
- Faculty Hospital Olomouc
- Palacký University Olomouc
- Internal grant of Palacký University
- Internal grant of Faculty Hospital Olomouc, MH CZ—DRO
Zitieren
APA
Ludikova, B., Sochorcova, L., Jaksic, D., Hlusickova Kapralova, K., & Horvathova, M. (2025). Clinical and Molecular Clues to Diagnosing Hereditary Hyperferritinemia-Cataract Syndrome: Case Report and Literature Review. Genes. https://doi.org/10.3390/genes16111381
Vancouver
Ludikova B, Sochorcova L, Jaksic D, Hlusickova Kapralova K, Horvathova M. Clinical and Molecular Clues to Diagnosing Hereditary Hyperferritinemia-Cataract Syndrome: Case Report and Literature Review. Genes. 2025. doi:10.3390/genes16111381
BibTeX
@article{Ludikova2025,
author = {Ludikova, Barbora and Sochorcova, Lucie and Jaksic, Damjan and Hlusickova Kapralova, Katarina and Horvathova, Monika},
title = {Clinical and Molecular Clues to Diagnosing Hereditary Hyperferritinemia-Cataract Syndrome: Case Report and Literature Review},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16111381}
}
EUVIMED